Alyeska Investment Group
OYST

Alyeska Investment Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Alyeska Investment Group’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,898
Closed -$400K – 947
2021
Q1 		$400K Hold
21,898
– – 0.01% 683
2020
Q4 		$412K Buy
21,898
+2,826
+15% +$60.9K 0.01% 457
2020
Q3 		$403K Sell
19,072
-73,710
-79% -$1.72M 0.01% 428
2020
Q2 		$2.68M Buy
+92,782
New +$2.8M 0.04% 336

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Alyeska Investment Group's OYST Position: Q2 2021 in Review

Alyeska Investment Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2021, closing a stake of 21,898 shares — an estimated $400K sold.

Alyeska Investment Group first reported a position in OYST in Q2 2020 and held it in 4 quarters. The position peaked at $2.68M in Q2 2020. 58 funds tracked by Wall St. Rank hold OYST as of Q2 2021.

  • Alyeska Investment Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 21,898 Oyster Point Pharma, Inc. Common Stock shares in Q2 2021, an estimated $400K.
  • Alyeska Investment Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Alyeska Investment Group's Oyster Point Pharma, Inc. Common Stock position peaked at $2.68M in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.